相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。STAT3-driven transcription depends upon the dimethylation of K49 by EZH2
Maupali Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
The New American Joint Committee on Cancer/International Union Against Cancer Staging System for Adenocarcinoma of the Stomach: Increased Complexity without Clear Improvement in Predictive Accuracy
Johan L. Dikken et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Polycomb Protein EZH2 Regulates Tumor Invasion via the Transcriptional Repression of the Metastasis Suppressor RKIP in Breast and Prostate Cancer
Gang Ren et al.
CANCER RESEARCH (2012)
3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
Tetsuhiro Chiba et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells
Amir Avan et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes
Karolina Holm et al.
MOLECULAR ONCOLOGY (2012)
Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells
Junko Kikuchi et al.
LUNG CANCER (2012)
The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells
Yong Jae Shin et al.
PLOS ONE (2012)
Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder
Hang Wang et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells
Hui Ying Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Comparison of 6th and 7th AJCC TNM Staging Classification for Carcinoma of the Stomach in China
Miao-zhen Qiu et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
Jianbiao Zhou et al.
BLOOD (2011)
Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer
Maria E. Gonzalez et al.
CANCER RESEARCH (2011)
IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Michael S. Anglesio et al.
CLINICAL CANCER RESEARCH (2011)
Targeting of EZH2 to a defined genomic site is sufficient for recruitment of Dnmt3a but not de novo DNA methylation
Margaret Rush et al.
Epigenetics (2010)
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
Yi Li et al.
GUT (2010)
Expression of polycomb protein EZH2 in multi-stage tissues of gastric carcinogenesis
Gan Hui Cai et al.
JOURNAL OF DIGESTIVE DISEASES (2010)
Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression
Jill J. Ranger et al.
CANCER RESEARCH (2009)
EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
STAT3 expression in gastric cancer indicates a poor prognosis
Dae-Young Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1
M. E. Gonzalez et al.
ONCOGENE (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1 (Publication with Expression of Concern. See vol. 78, pg. 5184, 2018)
Kwang Seok Ahn et al.
CANCER RESEARCH (2008)
Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation
Satoshi Fujii et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Multivariate prognostic study on large gastric cancer
Norio Shiraishi et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2
Kelly M. McGarvey et al.
CANCER RESEARCH (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer
Eliseo Mattioli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Molecular biology of gastric cancer
A. Cervantes et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2007)
STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis
Louise M. Judd et al.
GASTROENTEROLOGY (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Incidence and mortality of gastric cancer in China
Ling Yang
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1
I Hernández-Muñoz et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype
PA Croonquist et al.
ONCOGENE (2005)
Different Ezh2-containing complexes target methylation of histone H1 or nucleosomal histone H3
A Kuzmichev et al.
MOLECULAR CELL (2004)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
The use of molecular biology in diagnosis and prognosis of gastric cancer
KF Becker et al.
SURGICAL ONCOLOGY-OXFORD (2000)
分享论文
